Seroprevalence and factors associated with seropositivity to equine arteritis virus in Spanish Purebred horses in Spain
Summary Reasons for performing study Equine viral arteritis (EVA), a disease caused by infection with the equine arteritis virus (EAV), is present in many European countries. In Spain, the last confirmed outbreak was reported in 1992 and there is a paucity of seroprevalence studies. The disease has...
Gespeichert in:
Veröffentlicht in: | Equine veterinary journal 2016-09, Vol.48 (5), p.573-577 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 577 |
---|---|
container_issue | 5 |
container_start_page | 573 |
container_title | Equine veterinary journal |
container_volume | 48 |
creator | Cruz, F. Fores, P. Mughini-Gras, L. Ireland, J. Moreno, M. A. Newton, R. |
description | Summary
Reasons for performing study
Equine viral arteritis (EVA), a disease caused by infection with the equine arteritis virus (EAV), is present in many European countries. In Spain, the last confirmed outbreak was reported in 1992 and there is a paucity of seroprevalence studies. The disease has a major impact on the equine breeding industry, which is mainly represented by Spanish Purebred (SP) horses in Spain.
Objectives
To estimate the seroprevalence of EAV in the breeding SP horse population in central Spain and identify potential horse and studfarm level factors associated with seropositivity to EAV.
Study design
Cross‐sectional study.
Methods
Individual serum samples from 555 SP horses, collected between September 2011 and November 2013 at 35 studfarms, were tested using a commercially available EAV antibody ELISA and seroneutralisation as the World Organisation for Animal Health reference confirmation test for samples with positive and equivocal results. Data on factors putatively associated with seropositivity to EAV were collected via a questionnaire and examined using random effects logistic regression for analysis of clustered data.
Results
Equine arteritis virus seroprevalence in the SP breeding population in central Spain standardised for the sex distribution of the reference horse population, was estimated to be 16.8% (95% confidence interval 5.2–28.5%). Increasing numbers of breeding mares on the studfarm and increasing percentage of mares with reproductive problems during the last 12 months were identified as being positively associated with EAV seropositivity. Mares vaccinated against Equine herpesvirus‐1 (EHV‐1) and/or ‐4 (EHV‐4) were also positively associated with EAV seropositivity.
Conclusions
These findings are of importance to ensure appropriate biosecurity measures for studfarms are carried out and may help facilitate the development of an EVA surveillance programme in the SP breeding horse population. |
doi_str_mv | 10.1111/evj.12500 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1811300377</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1811300377</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4520-5a6756b437a528c82edc12522615477121ed0e8da86136ad540a4668ea29603f3</originalsourceid><addsrcrecordid>eNqNkc1OGzEURi3UClLaRV-gstRNWQz432aJKKStEFCFwtJyZm4Up5NxsD1J8_Y1DWGBVIQ3tuzzHen6Q-gjJYe0rCNYzg4pk4TsoAEjglWcE_UGDcpRVlQJsYfepTQjhHMm2C7aY4ppowkZoNUIYlhEWLoWuhqw6xo8cXUOMWGXUqi9y9Dglc9TnB7QkHz2S5_XOAcM973vSihmiOU64aWPfcK-w6OF63ya4us-wjgWw7QYYfvku_fo7cS1CT487vvo1_nZzem36uJq-P305KKqhWSkkk5pqcaCayeZqQ2Dpi6TMqaoFFpTRqEhYBpnFOXKNVIQJ5Qy4NixInzC99GXjXcRw30PKdu5TzW0resg9MlSIxQvai5fgVLKyx9qXdDPz9BZ6GNXBrH0mGktCVfiRcpQoomk1BTqYEPVMaQUYWIX0c9dXFtK7EO9ttRr_9Vb2E-Pxn48h-aJ3PZZgKMNsPItrP9vsme3P7bKapPwKcOfp4SLv63SXEt7dzm0_Cflo8vhjf3K_wLBSrxN</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1810705118</pqid></control><display><type>article</type><title>Seroprevalence and factors associated with seropositivity to equine arteritis virus in Spanish Purebred horses in Spain</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Cruz, F. ; Fores, P. ; Mughini-Gras, L. ; Ireland, J. ; Moreno, M. A. ; Newton, R.</creator><creatorcontrib>Cruz, F. ; Fores, P. ; Mughini-Gras, L. ; Ireland, J. ; Moreno, M. A. ; Newton, R.</creatorcontrib><description>Summary
Reasons for performing study
Equine viral arteritis (EVA), a disease caused by infection with the equine arteritis virus (EAV), is present in many European countries. In Spain, the last confirmed outbreak was reported in 1992 and there is a paucity of seroprevalence studies. The disease has a major impact on the equine breeding industry, which is mainly represented by Spanish Purebred (SP) horses in Spain.
Objectives
To estimate the seroprevalence of EAV in the breeding SP horse population in central Spain and identify potential horse and studfarm level factors associated with seropositivity to EAV.
Study design
Cross‐sectional study.
Methods
Individual serum samples from 555 SP horses, collected between September 2011 and November 2013 at 35 studfarms, were tested using a commercially available EAV antibody ELISA and seroneutralisation as the World Organisation for Animal Health reference confirmation test for samples with positive and equivocal results. Data on factors putatively associated with seropositivity to EAV were collected via a questionnaire and examined using random effects logistic regression for analysis of clustered data.
Results
Equine arteritis virus seroprevalence in the SP breeding population in central Spain standardised for the sex distribution of the reference horse population, was estimated to be 16.8% (95% confidence interval 5.2–28.5%). Increasing numbers of breeding mares on the studfarm and increasing percentage of mares with reproductive problems during the last 12 months were identified as being positively associated with EAV seropositivity. Mares vaccinated against Equine herpesvirus‐1 (EHV‐1) and/or ‐4 (EHV‐4) were also positively associated with EAV seropositivity.
Conclusions
These findings are of importance to ensure appropriate biosecurity measures for studfarms are carried out and may help facilitate the development of an EVA surveillance programme in the SP breeding horse population.</description><identifier>ISSN: 0425-1644</identifier><identifier>EISSN: 2042-3306</identifier><identifier>DOI: 10.1111/evj.12500</identifier><identifier>PMID: 26278700</identifier><identifier>CODEN: EQVJAI</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Alphaarterivirus equid ; Animal health ; Animal husbandry ; Animal populations ; Animals ; antibodies ; arteritis ; Arteritis Virus, Equine - isolation & purification ; Arterivirus Infections - blood ; Arterivirus Infections - epidemiology ; Arterivirus Infections - veterinary ; Arterivirus Infections - virology ; biosecurity ; blood serum ; Breeding ; confidence interval ; Confidence intervals ; cross-sectional studies ; Data processing ; Enzyme-linked immunosorbent assay ; Equid alphaherpesvirus 1 ; equine viral arteritis ; Female ; Horse ; Horse Diseases - blood ; Horse Diseases - epidemiology ; Horse Diseases - prevention & control ; Horse Diseases - virology ; Horses ; industry ; Infections ; livestock breeding ; Male ; mares ; monitoring ; Odds Ratio ; Population ; Population Surveillance ; purebreds ; questionnaires ; regression analysis ; Risk Factors ; Seroepidemiologic Studies ; seroprevalence ; Spain ; Spain - epidemiology ; Vaccination ; Viral Vaccines - immunology ; Viruses</subject><ispartof>Equine veterinary journal, 2016-09, Vol.48 (5), p.573-577</ispartof><rights>2015 EVJ Ltd</rights><rights>2015 EVJ Ltd.</rights><rights>2016 EVJ Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4520-5a6756b437a528c82edc12522615477121ed0e8da86136ad540a4668ea29603f3</citedby><cites>FETCH-LOGICAL-c4520-5a6756b437a528c82edc12522615477121ed0e8da86136ad540a4668ea29603f3</cites><orcidid>0000-0002-1142-3944</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fevj.12500$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fevj.12500$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26278700$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cruz, F.</creatorcontrib><creatorcontrib>Fores, P.</creatorcontrib><creatorcontrib>Mughini-Gras, L.</creatorcontrib><creatorcontrib>Ireland, J.</creatorcontrib><creatorcontrib>Moreno, M. A.</creatorcontrib><creatorcontrib>Newton, R.</creatorcontrib><title>Seroprevalence and factors associated with seropositivity to equine arteritis virus in Spanish Purebred horses in Spain</title><title>Equine veterinary journal</title><addtitle>Equine Vet J</addtitle><description>Summary
Reasons for performing study
Equine viral arteritis (EVA), a disease caused by infection with the equine arteritis virus (EAV), is present in many European countries. In Spain, the last confirmed outbreak was reported in 1992 and there is a paucity of seroprevalence studies. The disease has a major impact on the equine breeding industry, which is mainly represented by Spanish Purebred (SP) horses in Spain.
Objectives
To estimate the seroprevalence of EAV in the breeding SP horse population in central Spain and identify potential horse and studfarm level factors associated with seropositivity to EAV.
Study design
Cross‐sectional study.
Methods
Individual serum samples from 555 SP horses, collected between September 2011 and November 2013 at 35 studfarms, were tested using a commercially available EAV antibody ELISA and seroneutralisation as the World Organisation for Animal Health reference confirmation test for samples with positive and equivocal results. Data on factors putatively associated with seropositivity to EAV were collected via a questionnaire and examined using random effects logistic regression for analysis of clustered data.
Results
Equine arteritis virus seroprevalence in the SP breeding population in central Spain standardised for the sex distribution of the reference horse population, was estimated to be 16.8% (95% confidence interval 5.2–28.5%). Increasing numbers of breeding mares on the studfarm and increasing percentage of mares with reproductive problems during the last 12 months were identified as being positively associated with EAV seropositivity. Mares vaccinated against Equine herpesvirus‐1 (EHV‐1) and/or ‐4 (EHV‐4) were also positively associated with EAV seropositivity.
Conclusions
These findings are of importance to ensure appropriate biosecurity measures for studfarms are carried out and may help facilitate the development of an EVA surveillance programme in the SP breeding horse population.</description><subject>Alphaarterivirus equid</subject><subject>Animal health</subject><subject>Animal husbandry</subject><subject>Animal populations</subject><subject>Animals</subject><subject>antibodies</subject><subject>arteritis</subject><subject>Arteritis Virus, Equine - isolation & purification</subject><subject>Arterivirus Infections - blood</subject><subject>Arterivirus Infections - epidemiology</subject><subject>Arterivirus Infections - veterinary</subject><subject>Arterivirus Infections - virology</subject><subject>biosecurity</subject><subject>blood serum</subject><subject>Breeding</subject><subject>confidence interval</subject><subject>Confidence intervals</subject><subject>cross-sectional studies</subject><subject>Data processing</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Equid alphaherpesvirus 1</subject><subject>equine viral arteritis</subject><subject>Female</subject><subject>Horse</subject><subject>Horse Diseases - blood</subject><subject>Horse Diseases - epidemiology</subject><subject>Horse Diseases - prevention & control</subject><subject>Horse Diseases - virology</subject><subject>Horses</subject><subject>industry</subject><subject>Infections</subject><subject>livestock breeding</subject><subject>Male</subject><subject>mares</subject><subject>monitoring</subject><subject>Odds Ratio</subject><subject>Population</subject><subject>Population Surveillance</subject><subject>purebreds</subject><subject>questionnaires</subject><subject>regression analysis</subject><subject>Risk Factors</subject><subject>Seroepidemiologic Studies</subject><subject>seroprevalence</subject><subject>Spain</subject><subject>Spain - epidemiology</subject><subject>Vaccination</subject><subject>Viral Vaccines - immunology</subject><subject>Viruses</subject><issn>0425-1644</issn><issn>2042-3306</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1OGzEURi3UClLaRV-gstRNWQz432aJKKStEFCFwtJyZm4Up5NxsD1J8_Y1DWGBVIQ3tuzzHen6Q-gjJYe0rCNYzg4pk4TsoAEjglWcE_UGDcpRVlQJsYfepTQjhHMm2C7aY4ppowkZoNUIYlhEWLoWuhqw6xo8cXUOMWGXUqi9y9Dglc9TnB7QkHz2S5_XOAcM973vSihmiOU64aWPfcK-w6OF63ya4us-wjgWw7QYYfvku_fo7cS1CT487vvo1_nZzem36uJq-P305KKqhWSkkk5pqcaCayeZqQ2Dpi6TMqaoFFpTRqEhYBpnFOXKNVIQJ5Qy4NixInzC99GXjXcRw30PKdu5TzW0resg9MlSIxQvai5fgVLKyx9qXdDPz9BZ6GNXBrH0mGktCVfiRcpQoomk1BTqYEPVMaQUYWIX0c9dXFtK7EO9ttRr_9Vb2E-Pxn48h-aJ3PZZgKMNsPItrP9vsme3P7bKapPwKcOfp4SLv63SXEt7dzm0_Cflo8vhjf3K_wLBSrxN</recordid><startdate>201609</startdate><enddate>201609</enddate><creator>Cruz, F.</creator><creator>Fores, P.</creator><creator>Mughini-Gras, L.</creator><creator>Ireland, J.</creator><creator>Moreno, M. A.</creator><creator>Newton, R.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><orcidid>https://orcid.org/0000-0002-1142-3944</orcidid></search><sort><creationdate>201609</creationdate><title>Seroprevalence and factors associated with seropositivity to equine arteritis virus in Spanish Purebred horses in Spain</title><author>Cruz, F. ; Fores, P. ; Mughini-Gras, L. ; Ireland, J. ; Moreno, M. A. ; Newton, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4520-5a6756b437a528c82edc12522615477121ed0e8da86136ad540a4668ea29603f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Alphaarterivirus equid</topic><topic>Animal health</topic><topic>Animal husbandry</topic><topic>Animal populations</topic><topic>Animals</topic><topic>antibodies</topic><topic>arteritis</topic><topic>Arteritis Virus, Equine - isolation & purification</topic><topic>Arterivirus Infections - blood</topic><topic>Arterivirus Infections - epidemiology</topic><topic>Arterivirus Infections - veterinary</topic><topic>Arterivirus Infections - virology</topic><topic>biosecurity</topic><topic>blood serum</topic><topic>Breeding</topic><topic>confidence interval</topic><topic>Confidence intervals</topic><topic>cross-sectional studies</topic><topic>Data processing</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Equid alphaherpesvirus 1</topic><topic>equine viral arteritis</topic><topic>Female</topic><topic>Horse</topic><topic>Horse Diseases - blood</topic><topic>Horse Diseases - epidemiology</topic><topic>Horse Diseases - prevention & control</topic><topic>Horse Diseases - virology</topic><topic>Horses</topic><topic>industry</topic><topic>Infections</topic><topic>livestock breeding</topic><topic>Male</topic><topic>mares</topic><topic>monitoring</topic><topic>Odds Ratio</topic><topic>Population</topic><topic>Population Surveillance</topic><topic>purebreds</topic><topic>questionnaires</topic><topic>regression analysis</topic><topic>Risk Factors</topic><topic>Seroepidemiologic Studies</topic><topic>seroprevalence</topic><topic>Spain</topic><topic>Spain - epidemiology</topic><topic>Vaccination</topic><topic>Viral Vaccines - immunology</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cruz, F.</creatorcontrib><creatorcontrib>Fores, P.</creatorcontrib><creatorcontrib>Mughini-Gras, L.</creatorcontrib><creatorcontrib>Ireland, J.</creatorcontrib><creatorcontrib>Moreno, M. A.</creatorcontrib><creatorcontrib>Newton, R.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>Equine veterinary journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cruz, F.</au><au>Fores, P.</au><au>Mughini-Gras, L.</au><au>Ireland, J.</au><au>Moreno, M. A.</au><au>Newton, R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Seroprevalence and factors associated with seropositivity to equine arteritis virus in Spanish Purebred horses in Spain</atitle><jtitle>Equine veterinary journal</jtitle><addtitle>Equine Vet J</addtitle><date>2016-09</date><risdate>2016</risdate><volume>48</volume><issue>5</issue><spage>573</spage><epage>577</epage><pages>573-577</pages><issn>0425-1644</issn><eissn>2042-3306</eissn><coden>EQVJAI</coden><abstract>Summary
Reasons for performing study
Equine viral arteritis (EVA), a disease caused by infection with the equine arteritis virus (EAV), is present in many European countries. In Spain, the last confirmed outbreak was reported in 1992 and there is a paucity of seroprevalence studies. The disease has a major impact on the equine breeding industry, which is mainly represented by Spanish Purebred (SP) horses in Spain.
Objectives
To estimate the seroprevalence of EAV in the breeding SP horse population in central Spain and identify potential horse and studfarm level factors associated with seropositivity to EAV.
Study design
Cross‐sectional study.
Methods
Individual serum samples from 555 SP horses, collected between September 2011 and November 2013 at 35 studfarms, were tested using a commercially available EAV antibody ELISA and seroneutralisation as the World Organisation for Animal Health reference confirmation test for samples with positive and equivocal results. Data on factors putatively associated with seropositivity to EAV were collected via a questionnaire and examined using random effects logistic regression for analysis of clustered data.
Results
Equine arteritis virus seroprevalence in the SP breeding population in central Spain standardised for the sex distribution of the reference horse population, was estimated to be 16.8% (95% confidence interval 5.2–28.5%). Increasing numbers of breeding mares on the studfarm and increasing percentage of mares with reproductive problems during the last 12 months were identified as being positively associated with EAV seropositivity. Mares vaccinated against Equine herpesvirus‐1 (EHV‐1) and/or ‐4 (EHV‐4) were also positively associated with EAV seropositivity.
Conclusions
These findings are of importance to ensure appropriate biosecurity measures for studfarms are carried out and may help facilitate the development of an EVA surveillance programme in the SP breeding horse population.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>26278700</pmid><doi>10.1111/evj.12500</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-1142-3944</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0425-1644 |
ispartof | Equine veterinary journal, 2016-09, Vol.48 (5), p.573-577 |
issn | 0425-1644 2042-3306 |
language | eng |
recordid | cdi_proquest_miscellaneous_1811300377 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Alphaarterivirus equid Animal health Animal husbandry Animal populations Animals antibodies arteritis Arteritis Virus, Equine - isolation & purification Arterivirus Infections - blood Arterivirus Infections - epidemiology Arterivirus Infections - veterinary Arterivirus Infections - virology biosecurity blood serum Breeding confidence interval Confidence intervals cross-sectional studies Data processing Enzyme-linked immunosorbent assay Equid alphaherpesvirus 1 equine viral arteritis Female Horse Horse Diseases - blood Horse Diseases - epidemiology Horse Diseases - prevention & control Horse Diseases - virology Horses industry Infections livestock breeding Male mares monitoring Odds Ratio Population Population Surveillance purebreds questionnaires regression analysis Risk Factors Seroepidemiologic Studies seroprevalence Spain Spain - epidemiology Vaccination Viral Vaccines - immunology Viruses |
title | Seroprevalence and factors associated with seropositivity to equine arteritis virus in Spanish Purebred horses in Spain |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T04%3A46%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Seroprevalence%20and%20factors%20associated%20with%20seropositivity%20to%20equine%20arteritis%20virus%20in%20Spanish%20Purebred%20horses%20in%20Spain&rft.jtitle=Equine%20veterinary%20journal&rft.au=Cruz,%20F.&rft.date=2016-09&rft.volume=48&rft.issue=5&rft.spage=573&rft.epage=577&rft.pages=573-577&rft.issn=0425-1644&rft.eissn=2042-3306&rft.coden=EQVJAI&rft_id=info:doi/10.1111/evj.12500&rft_dat=%3Cproquest_cross%3E1811300377%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1810705118&rft_id=info:pmid/26278700&rfr_iscdi=true |